Stabilized Lipid Coated Lipoplexes for the Delivery of Antisense Oligonucleotides to Liver Endothelial Cells In Vitro and In Vivo

References

• Allen, T.M. and Cullis, P.R. (2004) “Drug delivery systems: entering the mainstream”, Science 303, 1818– 1822.
   PubMed Web of Science ®Google Scholar
• Bartsch, M., Weeke-Klimp, A.H., Meijer, D.K., Scherphof, G.L. and Kamps, J.A. (2002) “Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells”, Pharm. Res. 19, 676– 680.
   PubMed Web of Science ®Google Scholar
• Bligh, E.G. and Dyer, W.J. (1959) “A rapid method of total lipid extraction and purification”, Can. J. Med. Sci. 37, 911– 917.
   Google Scholar
• Bo¨ttcher, C.J.F., Van Gent, C.M. and Pries, C. (1961) “A rapid and sensitive sub-micro phosphorus determination”, Anal. Chim. Acta 24, 204– 205.
   Google Scholar
• Brignole, C., Pagnan, G., Marimpietri, D., Cosimo, E., Allen, T.M., Ponzoni, M. and Pastorino, F. (2003) “Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment”, Cancer Lett. 197, 231– 235.
   PubMed Web of Science ®Google Scholar
• Daemen, T., Velinova, M., Regts, J., de Jager, M., Kalicharan, R., Donga, J., van der Want, J.J. and Scherphof, G.L. (1997) “Different intrahepatic distribution of phosphatidylglycerol and phosphatidyl- serine liposomes in the rat”, Hepatology 26, 416– 423.
   PubMed Web of Science ®Google Scholar
• Dass, C.R. (2002) “Vehicles for oligonucleotide delivery to tumours”, J. Pharm. Pharmacol. 54, 3– 27.
   PubMed Web of Science ®Google Scholar
• Dass, C.R. and Su, T. (2001) “Particle-mediated intravascular delivery of oligonucleotides to tumors: associated biology and lessons from genotherapy”, Drug Deliv. 8, 191– 213.
   PubMed Web of Science ®Google Scholar
• Fattal, E., Dubernet, C. and Couvreur, P. (2001) “Liposome-based formulations for the delivery of oligonucleotides”, STP Pharma Sci. 11, 34– 44.
   Google Scholar
• Kamps, J.A.A.M. and Scherphof, G.L. (2003) “Liposomes in biological systems”, In: Torchilin, V.P. and Weissig, V., eds, Liposomes. A Practical Approach (Oxford University Press, Oxford), pp 267–288.
   Google Scholar
• Kamps, J.A., Swart, P.J., Morselt, H.W., Pauwels, R., De Bethune, M.P., De Clercq, E., Meijer, D.K. and Scherphof, G.L. (1996) “Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity”, Biochim. Biophys. Acta 1278, 183– 190.
   PubMed Web of Science ®Google Scholar
• Kamps, J.A., Morselt, H.W., Swart, P.J., Meijer, D.K. and Scherphof, G.L. (1997) “Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells”, Proc. Natl Acad. Sci. USA 94, 11681– 11685.
   PubMed Web of Science ®Google Scholar
• Kamps, J.A.A.M., Morselt, H.W.M., Meijer, D.K.F. and Scherphof, G.L. (2001) Development of a Lipid based Drug Delivery System for Modulation of Liversinusoidal Endothelial Cell Function. Cells of the Hepatic Sinusoids 8 (The Kupffer Cell Foundation, Leiden, The Netherlands), pp 144–147.
   Google Scholar
• Keidar, S., Kaplan, M. and Aviram, M. (1996) “Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation”, Arterioscler. Thromb. Vasc. Biol. 16, 97– 105.
   PubMed Web of Science ®Google Scholar
• Kleinherenbrink-Stins, M.F., van de Boom, J.H., Schouten, D., Roholl, P.J., Niels, v.d.H., Brouwer, A., Van Berkel, T.J. and Knook, D.L. (1991) “Visualization of the interaction of native and modified lipoproteins with parenchymal, endothelial and Kupffer cells from human liver”, Hepatology 14, 79–90.
   Google Scholar
• Kurreck, J. (2003) “Antisense technologies. Improvement through novel chemical modifications”, Eur. J. Biochem. 270, 1628–1644.
   Web of Science ®Google Scholar
• Matteucci, M.D. and Wagner, R.W. (1996) “In pursuit of antisense”, Nature 384, 20– 22.
   PubMed Web of Science ®Google Scholar
• Opalinska, J.B. and Gewirtz, A.M. (2002) “Nucleic-acid therapeutics: basic principles and recent applications”, Nat. Rev. Drug Discov. 1, 503– 514.
   PubMed Web of Science ®Google Scholar
• Opalinska, J.B. and Gewirtz, A.M. (2003) “Therapeutic potential of antisense nucleic acid molecules”, Sci. STKE 2003, (206) pe47.
   PubMedGoogle Scholar
• Pastorino, F., Brignole, C., Marimpietri, D., Pagnan, G., Morando, A., Ribatti, D., Semple, S.C., Gambini, C., Allen, T.M. and Ponzoni, M. (2003) “Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models”, Clin. Cancer Res. 9, 4595– 4605.
   PubMed Web of Science ®Google Scholar
• Peterson, G.L., et al. (1977) “A simplification of the protein assay method of Lowry. Which is more generally applicable”, Anal. Biochem. 83, 346– 356.
   PubMed Web of Science ®Google Scholar
• Radler, J.O., Koltover, I., Salditt, T. and Safinya, C.R. (1997) “Structure of DNA-cationic liposome complexes: DNA intercalation in multi- lamellar membranes in distinct interhelical packing regimes”, Science 275, 810– 814.
   PubMed Web of Science ®Google Scholar
• Ruetten, H., Thiemermann, C. and Perretti, M. (1999) “Up-regulation of ICAM-1 expression on J774.2 macrophages by endotoxin involves activation of NF-kappaB but not protein tyrosine kinase: comparison to induction of iNOS”, Mediators Inflamm. 8, 77– 84.
   PubMed Web of Science ®Google Scholar
• Schatzlein, A.G. (2001) “Non-viral vectors in cancer gene therapy: principles and progress”, Anticancer Drugs 12, 275– 304.
   PubMed Web of Science ®Google Scholar
• Scherer, L.J. and Rossi, J.J. (2003) “Approaches for the sequence-specific knockdown of mRNA”, Nat. Biotechnol. 21, 1457– 1465.
   PubMed Web of Science ®Google Scholar
• Semple, S.C., Klimuk, S.K., Harasym, T.O., Dos, S.N., Ansell, S.M., Wong, K.F., Maurer, N., Stark, H., Cullis, P.R., Hope, M.J. and Scherrer, P. (2001) “Efficient encapsulation of antisense oligonucleo- tides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures”, Biochim. Biophys. Acta 1510, 152– 166.
   PubMed Web of Science ®Google Scholar
• Shi, F., Wasungu, L., Nomden, A., Stuart, M.C., Polushkin, E., Engberts, J.B. and Hoekstra, D. (2002) “Interference of poly(ethylene glycol)- lipid analogues with cationic-lipid-mediated delivery of oligonucleo- tides; role of lipid exchangeability and non-lamellar transitions”, Biochem. J. 366, 333– 341.
   PubMed Web of Science ®Google Scholar
• Simoes, S., Moreira, J.N., Fonseca, C., Duzgunes, N. and de Lima, M.C. (2004) “On the formulation of pH-sensitive liposomes with long circulation times”, Adv. Drug Deliv. Rev. 56, 947– 965.
   PubMed Web of Science ®Google Scholar
• Stuart, D.D. and Allen, T.M. (2000) “A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability”, Biochim. Biophys. Acta 1463, 219–229.
   PubMed Web of Science ®Google Scholar
• Stuart, D.D., Semple, S.C. and Allen, T.M. (2004) “High efficiency entrapment of antisense oligonucleotides in liposomes”, Methods Enzymol. 387, 171– 188.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.P., Sekirov, L., Saravolac, E.G., Wheeler, J.J., Tardi, P., Clow, K., Leng, E., Sun, R., Cullis, P.R. and Scherrer, P. (1999) “Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties”, Gene Ther. 6, 1438– 1447.
   PubMed Web of Science ®Google Scholar